NasdaqGS - Nasdaq Real Time Price • USD
LivaNova PLC (LIVN)
As of 11:06 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | 0.49 | 0.8 | 3 | 3.32 |
| Low Estimate | 0.43 | 0.72 | 2.96 | 3.19 |
| High Estimate | 0.53 | 0.87 | 3.04 | 3.45 |
| Year Ago EPS | 0.43 | 0.78 | 2.8 | 3 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 7 | 10 | 10 |
| Avg. Estimate | 278.66M | 305.94M | 1.21B | 1.27B |
| Low Estimate | 273.2M | 300.6M | 1.2B | 1.24B |
| High Estimate | 282.8M | 312.4M | 1.22B | 1.28B |
| Year Ago Sales | -- | 293.9M | 1.15B | 1.21B |
| Sales Growth (year/est) | -- | 4.10% | 4.80% | 4.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.39 | 0.54 | 0.64 | 0.77 |
| EPS Actual | 0.43 | 0.78 | 0.73 | 0.87 |
| Difference | 0.04 | 0.24 | 0.09 | 0.1 |
| Surprise % | 10.30% | 44.40% | 14.10% | 13.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.49 | 0.8 | 3 | 3.32 |
| 7 Days Ago | 0.49 | 0.8 | 3 | 3.32 |
| 30 Days Ago | 0.51 | 0.79 | 3 | 3.32 |
| 60 Days Ago | 0.49 | 0.79 | 2.99 | 3.31 |
| 90 Days Ago | 0.56 | 0.86 | 3.02 | 3.28 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | LIVN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 14.00% | -- | -- | 1.50% |
| Next Qtr. | 2.60% | -- | -- | 11.40% |
| Current Year | 7.10% | -- | -- | 5.20% |
| Next Year | 10.70% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -4.60% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -0.92% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Mizuho: Buy to Buy | 3/27/2024 |
| Reiterates | Needham: Buy to Buy | 3/20/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 2/27/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 2/26/2024 |
| Maintains | Baird: Neutral to Neutral | 2/22/2024 |
| Maintains | Mizuho: Buy to Buy | 2/22/2024 |
Related Tickers
NVRO Nevro Corp.
11.57
-7.51%
ITGR Integer Holdings Corporation
113.00
-8.33%
IRMD IRADIMED CORPORATION
41.67
-1.81%
AXNX Axonics, Inc.
66.56
-0.12%
AXGN AxoGen, Inc.
6.60
-3.93%
OFIX Orthofix Medical Inc.
13.06
-3.72%
IRTC iRhythm Technologies, Inc.
112.61
-3.28%
GKOS Glaukos Corporation
99.03
-1.88%
RXST RxSight, Inc.
51.97
-1.65%
TBIO Telesis Bio, Inc.
0.3200
-0.40%